Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.27CNY
−631.26 MCNY
728.83 MCNY
165.85 K
About INNOCARE PHARMA LIMITED
Sector
CEO
Jisong Cui
Headquarters
Beijing
Website
Founded
2015
ISIN
CNE100005P56
FIGI
BBG012J46M28
InnoCare Pharma Ltd. is a clinical-stage biopharmaceutical company. It engages in discovering, developing and commercializing drugs for the treatment of cancer and autoimmune diseases. The company was founded by Jisong Cui and Yigong Shi on November 3, 2015 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688428 is 12.68 CNY — it has decreased by −0.94% in the past 24 hours. Watch INNOCARE PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange INNOCARE PHARMA LIMITED stocks are traded under the ticker 688428.
688428 stock has fallen by −5.72% compared to the previous week, the month change is a 4.88% rise, over the last year INNOCARE PHARMA LIMITED has showed a 17.73% increase.
We've gathered analysts' opinions on INNOCARE PHARMA LIMITED future price: according to them, 688428 price has a max estimate of 13.00 CNY and a min estimate of 5.41 CNY. Watch 688428 chart and read a more detailed INNOCARE PHARMA LIMITED stock forecast: see what analysts think of INNOCARE PHARMA LIMITED and suggest that you do with its stocks.
688428 reached its all-time high on Feb 3, 2023 with the price of 16.99 CNY, and its all-time low was 7.28 CNY and was reached on Jun 18, 2024. View more price dynamics on 688428 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688428 stock is 5.92% volatile and has beta coefficient of 0.68. Track INNOCARE PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is INNOCARE PHARMA LIMITED there?
Today INNOCARE PHARMA LIMITED has the market capitalization of 19.15 B, it has decreased by −3.58% over the last week.
Yes, you can track INNOCARE PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
INNOCARE PHARMA LIMITED is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
688428 net income for the last quarter is −119.44 M CNY, while the quarter before that showed −142.40 M CNY of net income which accounts for 16.13% change. Track more INNOCARE PHARMA LIMITED financial stats to get the full picture.
No, 688428 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2024, the company has 1.09 K employees. See our rating of the largest employees — is INNOCARE PHARMA LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOCARE PHARMA LIMITED EBITDA is −578.62 M CNY, and current EBITDA margin is −83.53%. See more stats in INNOCARE PHARMA LIMITED financial statements.
Like other stocks, 688428 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOCARE PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOCARE PHARMA LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOCARE PHARMA LIMITED stock shows the buy signal. See more of INNOCARE PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.